1. Annual report 2024
  2. Research
  3. VERTAP

VERTAP

Research Group in addressing vertigo in primary care

  1. Improve the approach to vertigo in Primary Care.
  2. Improve the diagnosis and treatment of vertigo through an online training with face-to-face reinforcement (Projecteactual).
  3. Improve the approach to vertigo through an algorithm the action within the Ecap (Future project).

Group projects

  • Disease, cardiovascular risk and lifestyles in primary care (MARCEVAP). (SENIOR-23/5). ICS - Catalan Institute of Health. 2024-2026. IP: Yolanda Rando Matos.
  • Mobile app for performing nystagmographies incorporated into a diagnostic algorithm for benign paroxysmal peripheral vertigo. NYSTAVERT. Primary Care Foundation (FAP) - CAMFIC; Migranodearena Foundation. PI: José Luis Ballvé Moreno.
  • NystaREC. Barcelona Mobile Ventures, S.L. 2022-2025. PI: Eva Peguero Rodríguez. - Effectiveness of a training intervention to improve the approach to patients with vertigo in primary care. VERTAP clinical trial. (PI19/00736). Carlos III Health Institute. 2019-2024. PI: José Luis Ballvé Moreno.
  • App per a mòbils per fer nistagmografíes incorporades a un algoritme diagnòstic del vertigen perifèric paroxistic benigne. NYSTAVERT. Fundació d'Atenció Primària (FAP) - CAMFIC. IP: José Luis Ballvé Moreno.
  • NystaREC. Barcelona Mobile Ventures, S.L. 2022 IP: Eva Peguero Rodríguez.
  • Efectividad de una intervención formativa para mejorar el abordaje de los pacientes con vértigo en atención primaria. Ensayo clínico VERTAP. (PI19/00736). Instituto de Salud Carlos III. 2019-2024. IP: José Luis Ballvé Moreno.

Group publications

  • Muñoz RC, Benito CA, Abad MD, Roca JM. Primary care management of sexually transmitted infections (III). Viral hepatitis and HIV infection. Aten Primaria. 2025; 57(1):103048-103048. PMID:39276681.
  • Cruz A, Cuxart Graell A, Goncalves AQ, Vazquez Villegas J, Vallejo Godoy S, Salas Coronas J et al. Delivering an innovative multi-infection and female genital mutilation screening to high-risk migrant populations (ISMiHealth): study protocol of a cluster randomised controlled trial with embedded process evaluation. BMJ Open. 2024; 14(11):PMID:39496367.
  • Bonet Monné S, Urgell CV, Sáez MJP, Puertolás OC, Baena Díez JM, Pascual J et al. NSAIDs, analgesics, antiplatelet drugs, and decline in renal function: a retrospective case-control study with SIDIAP database. BMC Pharmacol Toxicol. 2024; 25(1):58-58. PMID:39198874.
  • Garcia Gil M, Alves Cabratosa L, Cunillera O, Blanch J, Martí Lluch R, Ponjoan A et al. Effectiveness of the low-density lipoprotein cholesterol goals in secondary cardiovascular prevention. Eur. J. Clin. Invest. 2024; 54(9):PMID:38828496.
  • García Sancha N, Corchado Cobos R, Blanco Gómez A, Cunillera Puértolas O, Marzo Castillejo M, Castillo Lluva S et al. Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human. Res Sq. PMID:38405932.

PROCEEDING PAPERS

  • Peguero Rodriguez E, Perez Patiño J, Ballve JL, Villar I, Rando Y, Almeda J et al. Starting point for improving the approach to vertigo in primary care. Br. J. Gen. Pract. 2023;73PMID:37479255.

Anar a l'inici